富祥药业: 内幕信息知情人登记制度

Core Points - The document outlines the insider information management system of Jiangxi Fuxiang Pharmaceutical Co., Ltd, aiming to ensure confidentiality and compliance with relevant laws and regulations [1][2][12] - The board of directors is responsible for managing insider information, with the chairman as the main person in charge and the board secretary handling the registration of insider information [1][2] Group 1: Insider Information Definition - Insider information refers to non-public information that significantly impacts the company's operations, finances, or market price of its securities [5][6] - Examples of insider information include major changes in equity structure, significant investments, important contracts, major debts, and changes in management [6][7][8] Group 2: Responsibilities of Insider Information Holders - Company directors, senior management, and other relevant personnel must maintain confidentiality and cooperate with the board secretary in registering insider information [2][3] - Insider information holders are prohibited from leaking information or trading based on insider knowledge before it is publicly disclosed [2][3][10] Group 3: Registration and Record-Keeping - The company must accurately record all individuals who have access to insider information before it is disclosed, including their names, positions, and the nature of the information [5][6] - A detailed record of the process leading to significant corporate actions must be maintained, including timelines and involved personnel [11][12] Group 4: Confidentiality Management and Accountability - Insider information holders are required to sign confidentiality agreements and are subject to penalties for violations, including potential legal action [10][11] - The company must conduct self-inspections regarding insider trading activities and report any violations to regulatory authorities [9][10]